most effective glp-1 for obesity treatment 2025 Targeted Peptide Weight Loss Drugs Market Size to Reach USD 193.44 Billion by 2034 GLP-1 therapies are changing obesity

9 Despite limited evidence, these recommendations were rapidly incorporated nationwide into routine practice for all sedated procedures (eg, endoscopy and cardiac catheterization) and operating rooms

The US adult obesity rate was about 40% from 2017 to 2020, and Goldman Sachs researchers estimated last year that the drugs could be prescribed to 15 million Americans by 2030

It mimics a hormone naturally released when you eat, which helps trigger insulin production and a feeling of fullness, explains Caroline Apovian, MD, codirector of the Center for Weight Management and Wellness at Brigham and Womens Hospital in Boston